In a 40-year-old woman evaluating menopause, what do follicle-stimulating hormone of 13.8 IU/L and luteinizing hormone of 5.2 IU/L indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FSH 13.8 and LH 5.2 Indicate Late Reproductive Stage or Early Perimenopause

These hormone levels suggest your patient is in the late reproductive stage approaching perimenopause, but she is NOT yet postmenopausal and likely still has ovulatory cycles. The FSH of 13.8 IU/L is elevated above the typical reproductive range but well below postmenopausal levels, while the LH remains in the normal reproductive range 1, 2.

Interpretation of These Specific Values

Your patient's FSH of 13.8 IU/L falls into a transitional zone:

  • Normal reproductive FSH: typically <10 IU/L in early follicular phase
  • Your patient's FSH: 13.8 IU/L - moderately elevated
  • Postmenopausal FSH: typically >40 IU/L (often 75+ IU/L) 3

Research shows that in women aged 45-49 years with regular cycles, mean FSH rises to approximately 13.0 IU/L, which closely matches your patient's value 4. This elevation reflects declining ovarian reserve and reduced inhibin production, but does not indicate menopause.

Critical Clinical Pitfalls to Avoid

Do not use a single FSH measurement to diagnose menopausal status 1, 2, 5. This is one of the most common errors in clinical practice. Here's why:

  • FSH levels fluctuate dramatically during the menopausal transition - a woman can have "postmenopausal" FSH levels (>40 IU/L) one month and then ovulate the next month 5
  • The frequently cited FSH cutoff of 40 IU/L is inappropriate for determining postmenopausal status 2
  • Ovulation and pregnancy remain possible even after observing elevated FSH levels 5
  • Estrogen therapy cannot be monitored using FSH levels because inhibin also regulates FSH secretion 1

What These Numbers Actually Mean

At age 40 with FSH 13.8 and LH 5.2:

  • Ovarian reserve is declining but not depleted
  • Regular ovulatory cycles are likely still occurring 4
  • Fertility is reduced but not absent - contraception remains necessary if pregnancy is undesired 5, 3
  • She is approximately 5-10 years away from menopause on average
  • The LH/FSH ratio is normal (not inverted), which is consistent with late reproductive stage rather than postmenopause

Proper Diagnostic Approach

Menopause is a clinical diagnosis based on 12 consecutive months of amenorrhea, not hormone levels 1. For your 40-year-old patient:

  • If she has regular menstrual cycles: She is premenopausal/late reproductive stage regardless of FSH
  • If she has irregular cycles: She is perimenopausal (FSH may range from normal to >40 IU/L) 5
  • If she has no menses for 12 months: She is postmenopausal (expect FSH >40-75 IU/L) 3

Population Context

Data from NHANES III shows that at FSH ≥15 IU/L, only 70% of women are postmenopausal, meaning 30% still have ovarian function 6. Your patient's FSH of 13.8 IU/L places her below this threshold, making continued ovarian function highly likely.

Practical Recommendations

Tell your patient:

  • She is NOT menopausal
  • Her ovaries are showing age-related changes consistent with her age
  • She should continue contraception if pregnancy is undesired
  • Menopause diagnosis requires 12 months without periods, not a blood test
  • Repeat hormone testing is unnecessary and unhelpful for tracking menopausal transition 1, 5

The declining inhibin levels that occur with aging cause FSH to rise progressively starting around age 43, while LH remains relatively stable until true menopause 4. Your patient's hormone pattern fits this physiologic trajectory perfectly.

Related Questions

In a 48-year-old woman suspected of entering menopause, which laboratory test should be ordered to confirm the onset: serum follicle‑stimulating hormone (FSH), serum prolactin, serum estradiol, or no additional testing?
Why is follicle‑stimulating hormone (FSH) elevated in a postmenopausal woman receiving testosterone and progesterone therapy?
What is the management plan for a 48-year-old female with elevated Follicle-Stimulating Hormone (FSH) levels?
What estradiol and follicle‑stimulating hormone (FSH) levels indicate that a middle‑aged woman has completed menopause?
What is the likely diagnosis and appropriate treatment for a 52-year-old woman with irregular menstrual bleeding, low estradiol level, and mildly elevated follicle‑stimulating hormone?
Is metoclopramide contraindicated in patients with intestinal ischemia?
Which antibiotic should be started empirically for a suspected gram‑positive cocci infection?
Can you teach me how to arrive at a diagnosis and differential diagnosis by listening to a patient’s history?
What additional baseline investigations are required before initiating secukinumab (Cosentyx) in a 10‑year‑old child with severe psoriasis vulgaris, beyond tuberculin skin test or chest radiograph, hepatitis B surface antigen and core antibody, hepatitis C antibody, HIV 1/2 antibody, complete blood count, renal and liver function tests, lipid profile, and review for inflammatory bowel disease symptoms?
What are the possible diagnoses for a 40‑year‑old patient who, after a 2½‑week sea voyage, presents with clouding of consciousness, a single episode of left‑hand numbness, worsening migraines, double vision, normal brain CT and carotid ultrasound, and short‑term memory impairment?
How can I learn to take a complete clinical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.